EMBECTA CORP. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 27 rows, 27 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-04-04: Reporting owner Curtis Shaun; Form 4/A; Security Stock Appreciation Rights; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-04-04: Reporting owner Mann Jeffrey Z; Form 4/A; Security Stock Appreciation Rights; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-04-04: Reporting owner Elguicze Jacob; Form 4/A; Security Stock Appreciation Rights; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-04-04: Reporting owner Kumar Ajay; Form 4/A; Security Stock Appreciation Rights; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
EMBC insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4/A | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,058 77,259 owned after | $31.40 exercise price | $31.40 | 2022-05-12 |
| 2022-04-04 | Mann Jeffrey Z Officer (SVP, GC, Head Corp. Dev., Secy) | 4/A | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +54,450 158,600 owned after | $31.40 exercise price | $31.40 | 2022-05-12 |
| 2022-04-04 | Elguicze Jacob Officer (SVP and CFO) | 4/A | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +54,450 158,600 owned after | $31.40 exercise price | $31.40 | 2022-05-12 |
| 2022-04-04 | Kumar Ajay Officer (SVP and CHRO) | 4/A | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,225 91,073 owned after | $31.40 exercise price | $31.40 | 2022-05-12 |
| 2022-04-04 | Kurdikar Devdatt Director, Officer (President and CEO) | 4/A | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +217,799 558,963 owned after | $31.40 exercise price | $31.40 | 2022-05-12 |
| 2022-04-04 | Kurdikar Devdatt Director, Officer (President and CEO) | 4/A | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +132,004 690,967 owned after | $31.40 exercise price | $31.40 | 2022-05-12 |
| 2022-04-04 | Elguicze Jacob Officer (SVP and CFO) | 4 | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,281 16,281 owned after | $31.40 exercise price | $31.40 | 2022-04-06 |
| 2022-04-04 | Kurdikar Devdatt Director, Officer (President and CEO) | 4 | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,122 65,122 owned after | $31.40 exercise price | $31.40 | 2022-04-06 |
| 2022-04-04 | Kurdikar Devdatt Director, Officer (President and CEO) | 4 | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,074 104,196 owned after | $31.40 exercise price | $31.40 | 2022-04-06 |
| 2022-04-04 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4 | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,699 5,699 owned after | $31.40 exercise price | $31.40 | 2022-04-06 |
| 2022-04-04 | Mann Jeffrey Z Officer (SVP, GC, Head Corp. Dev., Secy) | 4 | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,281 16,281 owned after | $31.40 exercise price | $31.40 | 2022-04-06 |
| 2022-04-04 | Kumar Ajay Officer (SVP and CHRO) | 4 | Stock Appreciation Rights Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,141 8,141 owned after | $31.40 exercise price | $31.40 | 2022-04-06 |
| 2022-04-01 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +12,957 12,957 owned after | $27.97 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +15,243 28,200 owned after | $29.48 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +2,806 31,006 owned after | $26.28 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +15,217 46,223 owned after | $26.28 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Curtis Shaun Officer (SVP, Global Manuf./Sup. Chain) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +11,978 58,201 owned after | $28.31 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Mann Jeffrey Z Officer (SVP, GC, Head Corp. Dev., Secy) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +104,150 104,150 owned after | $28.31 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Elguicze Jacob Officer (SVP and CFO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +104,150 104,150 owned after | $28.31 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kumar Ajay Officer (SVP and CHRO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +4,062 4,062 owned after | $27.97 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kumar Ajay Officer (SVP and CHRO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +10,038 14,100 owned after | $29.48 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kumar Ajay Officer (SVP and CHRO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +16,239 30,339 owned after | $26.28 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kumar Ajay Officer (SVP and CHRO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +4,867 35,206 owned after | $26.28 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kumar Ajay Officer (SVP and CHRO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +28,642 63,848 owned after | $28.31 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Capone Brian Officer (VP, CAO & Corp. Controller) | 4 | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +26,044 26,044 owned after | $28.31 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kurdikar Devdatt Director, Officer (President and CEO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +132,871 132,871 owned after | $29.27 exercise price | $30.50 | 2022-05-12 |
| 2022-04-01 | Kurdikar Devdatt Director, Officer (President and CEO) | 4/A | Stock Appreciation Rights Derivative · Direct | J Other acquisition or disposition (describe transaction) | +208,293 341,164 owned after | $28.31 exercise price | $30.50 | 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |